Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
- PMID: 22011294
- DOI: 10.1111/j.1440-1746.2011.06901.x
Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
Comment on
-
Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments.J Gastroenterol Hepatol. 2011 Nov;26(11):1612-8. doi: 10.1111/j.1440-1746.2011.06751.x. J Gastroenterol Hepatol. 2011. PMID: 21517968
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
